RAYLEE WEAVER-JENSEN: Open Payments
NPI 1023275427 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 71 payments from 19 companies in 2025. Trend: 2023 $699 · 2024 $1,086 · 2025 $2,143
Food & beverage: $2,143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $870 |
| PFIZER INC. | 17 | $328 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $130 |
| Exact Sciences Corporation | 5 | $104 |
| ABBVIE INC. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Lundbeck LLC | 4 | $92 |
| Dexcom, Inc. | 1 | $87 |
| Novo Nordisk Inc | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
Products named: FARXIGA, AIRSUPRA, NURTEC ODT, ELIQUIS, Kerendia, BREZTRI, UBRELVY, CAPLYTA.
Industry payments across WA — which companies pay providers there.
